Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
The original Diabetology Axcess formulation (chenodeoxycholate and propyl gallate in a 2:1 ratio wt:wt) has been applied in dogs, using a GLP-1 RA which has been modified to resist not only DPP4 attack, but also breakdown by intestinal proteases ( The work reported by others in dogs, as well as our own results reported here in pigs and rats, show that the Axcess formulation is able to deliver GLP-1 receptor agonists in effective amounts, even at low doses, to the intestinal mucosa
Im excited about the potential for peptides, but we need the science to match the excitement, Frank said
Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement website Available from: (2009)
And suddenly you're wondering: Wait is this because of my medication? If you're taking medications like Ozempic, Wegovy, or Mounjaro and you've noticed hair shedding, you're not imagining things
Any stated results are NOT guaranteed and may NOT be typical
Applications in Research Investigation of GHSR-1a receptor binding, selectivity, and signalling pathways Study of growth hormone secretagogue mechanisms independent of HPA axis activation Research into pituitary somatotroph function and GH release dynamics In vitro and in vivo comparison with other GHRP compounds (GHRP-2, GHRP-6, Hexarelin) Models examining GH/IGF-1 axis regulation and bone growth signalling Use as a selective reference compound in neuroendocrine and peptide signalling research Handling, Reconstitution & Stability Weigh under dry conditions
